Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PC360
In the News
The Changing Role of Utilization Review in Workers’ Comp
Workers' Comp
Article
5 Ways Apricus Referrals Help Adjusters Move Specialty Claims Forward
Specialty referrals can slow a claim when each service requires a different vendor, contact, update and bill.
Insurance Journal
Article
Turn Data Into Action: Jim Harris
Workers' Comp
Article
5 Ways to Double Your Productivity Gains from Referral Engine
Double-digit productivity gains in claims operations are achievable, but rarely fully captured. The difference comes down to execution.
Risk & Insurance
Article
Is Workers’ Comp’s Golden Era Transitioning to a New Normal? Three Threats that Could Reshape the Market
Workers' Comp
Podcast